Concepedia

Castle Funatake

CF

11

Publications

838

Citations

11

H-Index

1999

Active since

Affiliations

Oregon State University(Current)

Providence Portland Medical Center

Cancer Research Center

Oregon Health & Science University

Castle Funatake is an author at Oregon State University specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1999–2017

11

Publications

11

Blocking OX-40/OX-40 Ligand Interaction In Vitro and In Vivo Leads to Decreased T Cell Function and Amelioration of Experimental Allergic Encephalomyelitis

Andrew D. Weinberg, Keith W. Wegmann, Castle Funatake et al. · The Journal of Immunology · 1999 · 252 citations · Full text

Cutting Edge: Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo- <i>p</i> -dioxin Generates a Population of CD4+CD25+ Cells with Characteristics of Regulatory T Cells

Castle Funatake, Nikki B. Marshall, Linda B. Steppan et al. · The Journal of Immunology · 2005 · 212 citations · Full text

Induction of Anti-Mammary Cancer Immunity by Engaging the OX-40 Receptor in Vivo

Arden M. Morris, John T. Vetto, Trygg Ramstad et al. · Breast Cancer Research and Treatment · 2001 · 78 citations

, , +8

OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent

Rodney A. Prell, Dean E. Evans, Colin Thalhofer et al. · The Journal of Immunology · 2003 · 75 citations · Full text

2,3,7,8-Tetrachlorodibenzo-<i>p</i>-dioxin Alters the Differentiation of Alloreactive CD8<sup>+</sup>T Cells Toward a Regulatory T Cell Phenotype by a Mechanism that is Dependent on Aryl Hydrocarbon Receptor in CD4<sup>+</sup>T Cells

Castle Funatake, Nikki B. Marshall, Nancy I. Kerkvliet · Journal of Immunotoxicology · 2008 · 44 citations · Full text

, , +23

Rows per page

1–5 of 11